{"id":18580,"date":"2025-10-17T15:39:57","date_gmt":"2025-10-17T15:39:57","guid":{"rendered":"http:\/\/tezgyan.com\/index.php\/2025\/10\/17\/googles-ai-brings-hope-in-cancer-treatment-sundar-pichai-calls-it-a-milestone-tech-news\/"},"modified":"2025-10-17T15:39:57","modified_gmt":"2025-10-17T15:39:57","slug":"googles-ai-brings-hope-in-cancer-treatment-sundar-pichai-calls-it-a-milestone-tech-news","status":"publish","type":"post","link":"https:\/\/tezgyan.com\/index.php\/2025\/10\/17\/googles-ai-brings-hope-in-cancer-treatment-sundar-pichai-calls-it-a-milestone-tech-news\/","title":{"rendered":"Google’s AI Brings Hope In Cancer Treatment, Sundar Pichai Calls It A Milestone | Tech News"},"content":{"rendered":"


\n<\/p>\n

\n

Last Updated:<\/span>

Google DeepMind unveiled an AI model that decodes cancer cell behaviour, enabling new targeted therapies and advancing cancer treatment, as Sundar Pichai announced<\/h2>\n
<\/p>\n
\n
\n
\n
\"font\"<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\"DeepMind<\/p>\n

DeepMind AI model can convert cold tumours to hot ones. (Representational Image)<\/p>\n<\/figure>\n

In a remarkable leap for medical science, Google\u2019s artificial intelligence (AI) division, DeepMind, has unveiled a groundbreaking discovery in the field of cancer research. Partnering with Yale University, the tech giant claims that its new biological AI model has generated, and experimentally proven, a novel hypothesis that could transform the way cancer is understood and treated.<\/p>\n

Google CEO Sundar Pichai described the innovation as \u201ca milestone in cancer treatment”, highlighting how the AI model can help identify tumours that typically evade the body\u2019s immune defences. The model, based on Gemma, generated \u201ca novel hypothesis about cancer cellular behaviour, which scientists experimentally validated in living cells,” Pichai wrote on X, calling the achievement a major stride in the fusion of AI and medicine.<\/p>\n

How DeepMind AI\u2019s Model Works<\/p>\n

The newly developed model, known as Cell2Sentence-Scale 27B (C2S-Scale 27B), is a 27-billion-parametre foundation model built on Google\u2019s open-source Gemma AI family. Its primary purpose is to interpret the \u201clanguage of cells”, a task that involves decoding intricate biological data at a single-cell level.<\/p>\n

By doing so, the AI can spot patterns in how cancer cells behave, particularly those that form cold tumours, a type of cancerous growth that remains invisible to the immune system. This capacity to \u201cread” cell behaviour allows scientists to identify evasive tumours that conventional immunotherapy fails to target effectively.<\/p>\n

\n
\n

An exciting milestone for AI in science: Our C2S-Scale 27B foundation model, built with @Yale<\/a> and based on Gemma, generated a novel hypothesis about cancer cellular behavior, which scientists experimentally validated in living cells. With more preclinical and clinical tests,\u2026<\/p>\n

\u2014 Sundar Pichai (@sundarpichai) October 15, 2025<\/a><\/p>\n<\/blockquote>\n<\/div>\n

DeepMind and Yale researchers tested the AI\u2019s predictions in living cells, where experimental results validated the model\u2019s hypothesis about cancer cell behaviour. The discovery, experts said, could usher in a new generation of targeted cancer therapies and redefine the boundaries of computational biology.<\/p>\n

From Cold To Hot<\/h2>\n

One of the model\u2019s most striking achievements lies in its potential to convert cold tumours into hot ones. In medical terms, cold tumours have very few immune cells and weak antigen signals, making them hard to detect. Hot tumours, on the other hand, are rich in immune cells and are more easily destroyed through immunotherapy.<\/p>\n

The DeepMind AI model identified a conditional amplifier drug that could enhance immune recognition under certain biological conditions, effectively helping the body\u2019s defences \u201csee and attack” hidden tumours. To test its accuracy, the AI simulated the effects of more than 4,000 drugs, narrowing down those with the highest potential to boost immune response.<\/p>\n

Preliminary results, according to the research team, have been \u201csignificantly successful” across multiple tests. The Yale team will now explore the deeper mechanisms behind this immune amplification effect, marking the beginning of what DeepMind calls \u201ca new framework for biological discovery”.<\/p>\n

A Turning Point for AI in Medicine<\/h2>\n

While the research remains in its early stages and will undergo preclinical and clinical testing, scientists view this development as a major step forward in AI-assisted biology. The ability to generate and validate hypotheses at a cellular level, something that traditionally takes years, could dramatically accelerate the pace of medical innovation.<\/p>\n

First Published:<\/span><\/p>\n
\n

October 16, 2025, 19:59 IST<\/p>\n<\/div>\n<\/div>\n

News<\/a> tech<\/a> Google’s AI Brings Hope In Cancer Treatment, Sundar Pichai Calls It A Milestone<\/span><\/div>\n
\n
\n
Disclaimer: Comments reflect users\u2019 views, not News18\u2019s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use<\/a> and Privacy Policy<\/a>.<\/div>\n<\/div>\n<\/div>\n

Read More<\/span><\/p>\n<\/div>\n